Wells Fargo Maintains Overweight on Bio-Techne, Raises Price Target to $76
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Brandon Couillard maintains Bio-Techne (NASDAQ:TECH) with a Overweight and raises the price target from $70 to $76.
Wells Fargo analyst Brandon Couillard maintains Bio-Techne (NASDAQ:TECH) with a Overweight and raises the price target from $70 to $76.